Literature DB >> 3674801

Effect of levodopa treatment on contrast sensitivity in Parkinson's disease.

C Bulens1, J D Meerwaldt, G J Van der Wildt, J B Van Deursen.   

Abstract

We studied contrast sensitivity function in 10 parkinsonian patients before and after levodopa treatment. Pretreatment contrast sensitivity function was abnormal in 16 of the 20 eyes. After treatment, only high-frequency loss was observed in 6 eyes. All other types of deficit disappeared under treatment. These changes of contrast sensitivity function following treatment suggest that dopamine is a functional transmitter in the visual pathways.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3674801     DOI： 10.1002/ana.410220313

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  20 in total

Review 1.  Prefrontal Contributions to Attention and Working Memory.

Authors:  Zahra Bahmani; Kelsey Clark; Yaser Merrikhi; Adrienne Mueller; Warren Pettine; M Isabel Vanegas; Tirin Moore; Behrad Noudoost
Journal:  Curr Top Behav Neurosci       Date:  2019

2.  Visual contrast sensitivity in drug-induced Parkinsonism.

Authors:  C Bulens; J D Meerwaldt; G J van der Wildt; C J Keemink
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

3.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

4.  Positive and negative polarity contrast sensitivity measuring app.

Authors:  Alex D Hwang; Eli Peli
Journal:  IS&T Int Symp Electron Imaging       Date:  2016-02-14

Review 5.  Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.

Authors:  Eva Schaeffer; Daniela Berg
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

6.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

7.  Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

Authors:  O Blin; D Mestre; G Masson; G Serratrice
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 8.  [The eye as a window to the pathophysiology in Parkinson's syndromes].

Authors:  J Kassubek; A Danek; K Del Tredici-Braak; M W Greenlee; E H Pinkhardt
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

9.  Visual symptoms in Parkinson's disease.

Authors:  R A Armstrong
Journal:  Parkinsons Dis       Date:  2011-05-25

10.  Contrast Acuity With Different Colors in Parkinson's Disease.

Authors:  Harsh V Gupta; Nan Zhang; Erika Driver-Dunckley; Shyamal H Mehta; Thomas G Beach; Charles H Adler
Journal:  Mov Disord Clin Pract       Date:  2019-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.